Insys Therapeutics Inc. (INSY) Stock Price, Quote, News and Overview
NASDAQ:INSY - Nasdaq -
INSY Quote, Performance and Key Statistics
0.2911
0 (-1.36%)
The current stock price of INSY is 0.2911 null. In the past month the price decreased by -69.62%. In the past year, price decreased by -96.43%.
About INSY
Company Profile
Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray and Dronabinol SG capsule. Insys Therapeutics, Inc. is based in Phoenix, Arizona.
Company Info
Insys Therapeutics Inc.
1333 S. Spectrum Blvd Suite 100
Chandler AZ 85286
CEO: Saeed Motahari
Phone: 480-500-3127
Insys Therapeutics Inc. / INSY FAQ
What is the stock price of Insys Therapeutics Inc. today?
The current stock price of INSY is 0.2911 null. The price decreased by -1.36% in the last trading session.
What is the ticker symbol for Insys Therapeutics Inc. stock?
The exchange symbol of Insys Therapeutics Inc. is INSY and it is listed on the Nasdaq exchange.
On which exchange is INSY stock listed?
INSY stock is listed on the Nasdaq exchange.
What is Insys Therapeutics Inc. worth?
Insys Therapeutics Inc. (INSY) has a market capitalization of 21.71M null. This makes INSY a Nano Cap stock.
Should I buy Insys Therapeutics Inc. (INSY) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of INSY, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of INSY, evaluating the profitability, health, valuation and growth aspects
- Insys Therapeutics Inc. (INSY) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Insys Therapeutics Inc. (INSY) Sales and EPS estimates to see what analysts future expectations are.
- Insys Therapeutics Inc. (INSY) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Insys Therapeutics Inc. (INSY) Insider and Institutional Ownership to learn about the owners and their transactions.
- Insys Therapeutics Inc. (INSY) Stock Chart to make your own analysis
- Insys Therapeutics Inc. (INSY) Latest news and press-releases to stay up to date.
Does Insys Therapeutics Inc. (INSY) stock pay dividends?
INSY does not pay a dividend.
What is the Price/Earnings (PE) ratio of Insys Therapeutics Inc. (INSY)?
Insys Therapeutics Inc. (INSY) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.74).
INSY Technical Analysis
INSY Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to INSY. INSY has a bad profitability rating. Also its financial health evaluation is rather negative.
INSY Financial Highlights
Over the last trailing twelve months INSY reported a non-GAAP Earnings per Share(EPS) of -1.7400000000000002. The EPS decreased by -145.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -346.48% | ||
| ROA | -132.09% | ||
| ROE | 139.25% | ||
| Debt/Equity | -0.07 |
INSY Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 80% to INSY. The Buy consensus is the average rating of analysts ratings from 3 analysts.